SURG is trading at $0.43 (6% down) as the stock pulls back following a period of extreme volatility and no fresh company-specific news.
- The move follows a sharp -19.50% drop on July 6 and a significant +38.08% rally on July 2, characteristic of thin-liquidity microcap trading.
- Broader market sentiment is also cautious, with the S&P 500 down 0.30% and the Nasdaq down 0.66%, potentially adding pressure to the stock.